vs

Side-by-side financial comparison of Lakeside Holding Ltd (LSH) and VALUE LINE INC (VALU). Click either name above to swap in a different company.

VALUE LINE INC is the larger business by last-quarter revenue ($8.3M vs $7.0M, roughly 1.2× Lakeside Holding Ltd). VALUE LINE INC runs the higher net margin — 71.4% vs -22.6%, a 94.0% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs -7.7%).

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

Value Line, Inc. is a publicly traded investment research and financial publishing firm based in New York City. Founded in 1931 by Arnold Bernhard, Value Line is best known for publishing The Value Line Investment Survey, a stock analysis newsletter that tracks approximately 1,700 publicly traded stocks.

LSH vs VALU — Head-to-Head

Bigger by revenue
VALU
VALU
1.2× larger
VALU
$8.3M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+102.7% gap
LSH
95.0%
-7.7%
VALU
Higher net margin
VALU
VALU
94.0% more per $
VALU
71.4%
-22.6%
LSH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
LSH
LSH
VALU
VALU
Revenue
$7.0M
$8.3M
Net Profit
$-1.6M
$5.9M
Gross Margin
27.2%
Operating Margin
-21.3%
12.1%
Net Margin
-22.6%
71.4%
Revenue YoY
95.0%
-7.7%
Net Profit YoY
18.7%
14.5%
EPS (diluted)
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSH
LSH
VALU
VALU
Q1 26
$8.3M
Q4 25
$7.0M
$8.6M
Q3 25
$6.1M
$8.6M
Q2 25
$6.3M
$8.4M
Q1 25
$3.8M
$9.0M
Q4 24
$3.6M
$8.8M
Q3 24
$4.1M
$8.9M
Q2 24
$9.0M
Net Profit
LSH
LSH
VALU
VALU
Q1 26
$5.9M
Q4 25
$-1.6M
$5.7M
Q3 25
$-1.4M
$6.5M
Q2 25
$-893.1K
$4.0M
Q1 25
$-1.1M
$5.2M
Q4 24
$-1.9M
$5.7M
Q3 24
$-1.3M
$5.9M
Q2 24
$4.8M
Gross Margin
LSH
LSH
VALU
VALU
Q1 26
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Operating Margin
LSH
LSH
VALU
VALU
Q1 26
12.1%
Q4 25
-21.3%
17.7%
Q3 25
-20.8%
17.4%
Q2 25
-8.9%
9.9%
Q1 25
-28.2%
17.4%
Q4 24
-55.6%
19.7%
Q3 24
-32.5%
20.8%
Q2 24
16.5%
Net Margin
LSH
LSH
VALU
VALU
Q1 26
71.4%
Q4 25
-22.6%
66.4%
Q3 25
-22.2%
75.1%
Q2 25
-14.2%
47.1%
Q1 25
-28.2%
57.6%
Q4 24
-54.1%
64.3%
Q3 24
-32.7%
66.3%
Q2 24
53.1%
EPS (diluted)
LSH
LSH
VALU
VALU
Q1 26
Q4 25
$-0.08
Q3 25
$-0.09
Q2 25
$-0.11
Q1 25
$-0.14
Q4 24
$-0.26
Q3 24
$-0.18
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSH
LSH
VALU
VALU
Cash + ST InvestmentsLiquidity on hand
$1.6M
$92.5M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$12.2M
$107.8M
Total Assets
$24.3M
$151.0M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSH
LSH
VALU
VALU
Q1 26
$92.5M
Q4 25
$1.6M
$86.6M
Q3 25
$4.5M
$33.7M
Q2 25
$5.0M
$67.7M
Q1 25
$1.5M
$52.8M
Q4 24
$1.1M
$22.3M
Q3 24
$2.7M
$30.9M
Q2 24
$4.4M
Total Debt
LSH
LSH
VALU
VALU
Q1 26
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Stockholders' Equity
LSH
LSH
VALU
VALU
Q1 26
$107.8M
Q4 25
$12.2M
$105.5M
Q3 25
$7.0M
$103.0M
Q2 25
$2.8M
$99.7M
Q1 25
$749.8K
$99.0M
Q4 24
$1.6M
$96.7M
Q3 24
$3.6M
$93.9M
Q2 24
$90.8M
Total Assets
LSH
LSH
VALU
VALU
Q1 26
$151.0M
Q4 25
$24.3M
$147.9M
Q3 25
$18.6M
$148.2M
Q2 25
$14.4M
$144.5M
Q1 25
$9.9M
$143.6M
Q4 24
$9.8M
$140.0M
Q3 24
$10.8M
$138.6M
Q2 24
$136.0M
Debt / Equity
LSH
LSH
VALU
VALU
Q1 26
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSH
LSH
VALU
VALU
Operating Cash FlowLast quarter
$-453.5K
$5.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.89×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSH
LSH
VALU
VALU
Q1 26
$5.3M
Q4 25
$-453.5K
$3.0M
Q3 25
$-4.0M
$5.6M
Q2 25
$-483.7K
$20.2M
Q1 25
$-238.3K
$6.9M
Q4 24
$-530.2K
$3.1M
Q3 24
$-1.4M
$4.8M
Q2 24
$17.9M
Free Cash Flow
LSH
LSH
VALU
VALU
Q1 26
Q4 25
Q3 25
Q2 25
$-497.4K
$20.1M
Q1 25
$6.8M
Q4 24
$-560.5K
$3.0M
Q3 24
$-1.4M
$4.8M
Q2 24
$17.9M
FCF Margin
LSH
LSH
VALU
VALU
Q1 26
Q4 25
Q3 25
Q2 25
-7.9%
239.2%
Q1 25
75.3%
Q4 24
-15.6%
34.1%
Q3 24
-34.5%
53.7%
Q2 24
199.0%
Capex Intensity
LSH
LSH
VALU
VALU
Q1 26
0.0%
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.2%
2.1%
Q1 25
0.0%
1.2%
Q4 24
0.8%
0.7%
Q3 24
0.1%
0.0%
Q2 24
0.2%
Cash Conversion
LSH
LSH
VALU
VALU
Q1 26
0.89×
Q4 25
0.52×
Q3 25
0.86×
Q2 25
5.12×
Q1 25
1.33×
Q4 24
0.54×
Q3 24
0.81×
Q2 24
3.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

VALU
VALU

Segment breakdown not available.

Related Comparisons